A detailed history of Ikarian Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ikarian Capital, LLC holds 146,000 shares of AMGN stock, worth $38.3 Million. This represents 8.22% of its overall portfolio holdings.

Number of Shares
146,000
Previous 600 24233.33%
Holding current value
$38.3 Million
Previous $187,000 25056.15%
% of portfolio
8.22%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $7.73 Million - $8.43 Million
-25,000 Reduced 65.27%
13,300 $4.29 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $10.1 Million - $12.2 Million
38,300 New
38,300 $12 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $4.39 Million - $4.85 Million
20,000 New
20,000 $4.84 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.